These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


432 related items for PubMed ID: 24907115

  • 1. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
    Shao C, Sullivan JP, Girard L, Augustyn A, Yenerall P, Rodriguez-Canales J, Liu H, Behrens C, Shay JW, Wistuba II, Minna JD.
    Clin Cancer Res; 2014 Aug 01; 20(15):4154-66. PubMed ID: 24907115
    [Abstract] [Full Text] [Related]

  • 2. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
    Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, Honorio S, Xie Y, Scaglioni PP, DiMaio JM, Gazdar AF, Shay JW, Wistuba II, Minna JD.
    Cancer Res; 2010 Dec 01; 70(23):9937-48. PubMed ID: 21118965
    [Abstract] [Full Text] [Related]

  • 3. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
    Thomas ML, de Antueno R, Coyle KM, Sultan M, Cruickshank BM, Giacomantonio MA, Giacomantonio CA, Duncan R, Marcato P.
    Mol Oncol; 2016 Nov 01; 10(9):1485-1496. PubMed ID: 27592281
    [Abstract] [Full Text] [Related]

  • 4. Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.
    Corominas-Faja B, Oliveras-Ferraros C, Cuyàs E, Segura-Carretero A, Joven J, Martin-Castillo B, Barrajón-Catalán E, Micol V, Bosch-Barrera J, Menendez JA.
    Cell Cycle; 2013 Nov 01; 12(21):3390-404. PubMed ID: 24047698
    [Abstract] [Full Text] [Related]

  • 5. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
    Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee PW.
    Stem Cells; 2011 Jan 01; 29(1):32-45. PubMed ID: 21280157
    [Abstract] [Full Text] [Related]

  • 6. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
    Kurth I, Hein L, Mäbert K, Peitzsch C, Koi L, Cojoc M, Kunz-Schughart L, Baumann M, Dubrovska A.
    Oncotarget; 2015 Oct 27; 6(33):34494-509. PubMed ID: 26460734
    [Abstract] [Full Text] [Related]

  • 7. ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion.
    Zhang W, Liu Y, Hu H, Huang H, Bao Z, Yang P, Wang Y, You G, Yan W, Jiang T, Wang J, Zhang W.
    PLoS One; 2015 Oct 27; 10(11):e0142856. PubMed ID: 26575197
    [Abstract] [Full Text] [Related]

  • 8. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
    Luo Y, Dallaglio K, Chen Y, Robinson WA, Robinson SE, McCarter MD, Wang J, Gonzalez R, Thompson DC, Norris DA, Roop DR, Vasiliou V, Fujita M.
    Stem Cells; 2012 Oct 27; 30(10):2100-13. PubMed ID: 22887839
    [Abstract] [Full Text] [Related]

  • 9. ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.
    Kawakami R, Mashima T, Kawata N, Kumagai K, Migita T, Sano T, Mizunuma N, Yamaguchi K, Seimiya H.
    Cancer Sci; 2020 Mar 27; 111(3):962-973. PubMed ID: 31960523
    [Abstract] [Full Text] [Related]

  • 10. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
    Karimi-Busheri F, Zadorozhny V, Li T, Lin H, Shawler DL, Fakhrai H.
    J Stem Cells; 2011 Mar 27; 6(1):9-20. PubMed ID: 22997842
    [Abstract] [Full Text] [Related]

  • 11. Cancer Stem Cell Biomarkers in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer.
    Codony-Servat J, Codony-Servat C, Cardona AF, Giménez-Capitán A, Drozdowskyj A, Berenguer J, Bracht JWP, Ito M, Karachaliou N, Rosell R.
    Clin Lung Cancer; 2019 May 27; 20(3):167-177. PubMed ID: 30885551
    [Abstract] [Full Text] [Related]

  • 12. A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations.
    Canino C, Luo Y, Marcato P, Blandino G, Pass HI, Cioce M.
    Oncotarget; 2015 May 20; 6(14):12637-53. PubMed ID: 25868979
    [Abstract] [Full Text] [Related]

  • 13. High expression of ALDH1A3 might independently influence poor progression-free and overall survival in patients with glioma via maintaining glucose uptake and lactate production.
    Ni W, Xia Y, Luo L, Wen F, Hu D, Bi Y, Qi J.
    Cell Biol Int; 2020 Feb 20; 44(2):569-582. PubMed ID: 31642564
    [Abstract] [Full Text] [Related]

  • 14. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.
    Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, Lin J.
    Cancer Res; 2011 Dec 01; 71(23):7226-37. PubMed ID: 21900397
    [Abstract] [Full Text] [Related]

  • 15. miR-17-92/p38α Dysregulation Enhances Wnt Signaling and Selects Lgr6+ Cancer Stem-like Cells during Lung Adenocarcinoma Progression.
    Guinot A, Oeztuerk-Winder F, Ventura JJ.
    Cancer Res; 2016 Jul 01; 76(13):4012-22. PubMed ID: 27197183
    [Abstract] [Full Text] [Related]

  • 16. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
    Cheng P, Wang J, Waghmare I, Sartini S, Coviello V, Zhang Z, Kim SH, Mohyeldin A, Pavlyukov MS, Minata M, Valentim CL, Chhipa RR, Bhat KP, Dasgupta B, La Motta C, Kango-Singh M, Nakano I.
    Cancer Res; 2016 Dec 15; 76(24):7219-7230. PubMed ID: 27569208
    [Abstract] [Full Text] [Related]

  • 17. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
    Flahaut M, Jauquier N, Chevalier N, Nardou K, Balmas Bourloud K, Joseph JM, Barras D, Widmann C, Gross N, Renella R, Mühlethaler-Mottet A.
    BMC Cancer; 2016 Oct 10; 16(1):781. PubMed ID: 27724856
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
    Wang M, Wang W, Ding J, Wang J, Zhang J.
    Thorac Cancer; 2020 Feb 10; 11(2):379-388. PubMed ID: 31841274
    [Abstract] [Full Text] [Related]

  • 19. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
    Jiang J, Li Z, Yu C, Chen M, Tian S, Sun C.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):962-70. PubMed ID: 25444909
    [Abstract] [Full Text] [Related]

  • 20. [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].
    He J, Song X, Yu L, Li J, Qiao Z, Jiu R, Yu B, Liu X.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May 28; 31(5):625-9. PubMed ID: 25940289
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.